1024亚洲精品国产片_成人特黄a级毛片免费视频_欧美日韩国内另类综合在线_热播国产无码久久精品一级五月天不卡_日韩在线视频观看免费网站_波多野结衣AV网站_浓毛老太交欧美老妇热爱乱_嘿嘿视频app污免费下载观看_国产麻豆精品制服丝袜_最近中文字幕2018中文字幕

Expert forum

首頁 專家論壇 標(biāo)本專家Ligthart STFeatures in Breast, Colorectal and Prostate Cancer.
注冊

Ligthart STFeatures in Breast, Colorectal and Prostate Cancer.

2017-12-08 07:51來源:原版作者:Ligthart ST

BACKGROUND:

Presence of circulating tumor cells (CTC) in patients with metastatic breast, colorectal and prostate cancer is indicative for poor prognosis. An automated CTC (aCTC) algorithm developed previously to eliminate the variability in manual counting of CTC (mCTC) was used to extract morphological features. Here we validated the aCTC algorithm on CTC images from prostate, breast and colorectal cancer patients and investigated the role of quantitative morphological parameters.

METHODOLOGY:

Stored images of samples from patients with prostate, breast and colorectal cancer, healthy controls, benign breast and colorectal tumors were obtained using the CellSearch system. Images were analyzed for the presence of aCTC and their morphological parameters measured and correlated with survival.

RESULTS:

Overall survival hazard ratio was not significantly different for aCTC and mCTC. The number of CTC correlated strongest with survival, whereas CTC size, roundness and apoptosis features reached significance in univariate analysis, but not in multivariate analysis. One aCTC/7.5 ml of blood was found in 7 of 204 healthy controls and 9 of 694 benign tumors. In one patient with benign tumor 2 and another 9 aCTC were detected.

SIGNIFICANCE OF THE STUDY:

CTC can be identified and morphological features extracted by an algorithm on images stored by the CellSearch system and strongly correlate with clinical outcome in metastatic breast, colorectal and prostate cancer.

版權(quán)聲明:

本網(wǎng)站所有注明“來源:“陽普醫(yī)療”的文字、圖片和音視頻資料,版權(quán)均屬于陽普醫(yī)療所有,非經(jīng)授權(quán),任何媒體、網(wǎng)站或個人不得轉(zhuǎn)載,授權(quán)轉(zhuǎn)載時須注明

“來源:陽普醫(yī)療”。本網(wǎng)所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉(zhuǎn)載的媒體或個人可與我們聯(lián)系,我們將立即進(jìn)行刪除處理。

網(wǎng)友評論: